SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway

Cancer Letters

Volumn 354, Issue 2, 2014, Pages 417-426

  Hu, Ting Hua ^a   Yao, Yu ^a   Yu, Shuo ^a   Han, Li Li ^a   Wang, Wen Juan ^a   Guo, Hui ^a   Tian, Tao ^a   Ruan, Zhi Pin ^a   Kang, Xiao Min ^a   Wang, Jing ^a   Wang, Shu Hong ^a   Nan, Ke Jun ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Colorectal cancer; CXCR4; EMT; Invasion and metastasis; Wnt catenin

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; DICKKOPF 1 PROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; STROMAL CELL DERIVED FACTOR 1; UVOMORULIN; VIMENTIN; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; DKK1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ARTICLE; CANCER GROWTH; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; YOUNG ADULT; ANIMAL; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE COURSE; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; MOUSE; NUDE MOUSE; PATHOLOGY; WNT SIGNALING PATHWAY; XENOGRAFT;

ANIMALS; BETA CATENIN; CHEMOKINE CXCL12; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, NUDE; MIDDLE AGED; RECEPTORS, CXCR4; WNT SIGNALING PATHWAY;

EID: 84908011394     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.08.012     Document Type: Article

References (45)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin 2013, 63(2013):11-30.
2. Mano M.S., Duhoux F. Colon cancer: update on adjuvant therapy. Clin. Colorectal Cancer 2008, 7:178-183.
3. Gallagher D.J., Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology 2010, 78:237-248.
4. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
5. Fidler I.J. Molecular biology of cancer: invasion and metastasis. Cancer Princ. Pract. Oncol 1997, 5:135-152.
6. Wang Y.C., Hu X.B., He F., Feng F., Wang L., Li W., et al. Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4. J. Biol. Chem 2009, 284:15993-16003.
7. Burger J.A., Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
8. Egawa T., Kawabata K., Kawamoto H., Amada K., Okamoto R., Fujii N., et al. The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor. Immunity 2001, 15:323-334.
9. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
10. Hao L., Zhang C., Qiu Y., Wang L., Luo Y., Jin M., et al. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 2007, 253:34-42.
11. Saur D., Seidler B., Schneider G., Algül H., Beck R., Senekowitsch-Schmidtke R., et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 2005, 129:1237-1250.
12. Kato M., Kitayama J., Kazama S., Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 2003, 5:R144-R150.
13. Uchida D., Begum N.M., Almofti A., Nakashiro K.I., Kawamata H., Tateishi Y., et al. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp. Cell Res 2003, 290:289-302.
14. Kim J., Takeuchi H., Lam S.T., Turner R.R., Wang H.J., Kuo C., et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J. Clin. Oncol 2005, 23:2744-2753.
15. Matsusue R., Kubo H., Hisamori S., Okoshi K., Takagi H., Hida K., et al. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann. Surg. Oncol 2009, 16:2645-2653.
16. Zeelenberg I.S., Stalle L.R.V., Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003, 63:3833-3839.
17. He T.-C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
18. Tetsu O., McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
19. Wielenga V.J., Smits R., Korinek V., Smit L., Kielman M., Fodde R., et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol 1999, 154:515-523.
20. Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol 1999, 155:1033-1038.
21. Robbins D.H., Itzkowitz S.H. The molecular and genetic basis of colon cancer. Med. Clin. North. Am 2002, 86:1467-1495.
22. Brabletz T., Jung A., Reu S., Porzner M., Hlubek F., Kunz-Schughart L.A., et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10356-10361.
23. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
24. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest 2003, 112:1776-1784.
25. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest 2009, 119:1420-1428.
26. Zhang S.S., Han Z.-P., Jing Y.Y., Tao S.F., Li T.J., Wang H., et al. CD133+ CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med 2012, 10:85.
27. Wang Z., Ma Q., Liu Q., Yu H., Zhao L., Shen S., et al. Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. Br. J. Cancer 2008, 99:1695-1703.
28. Luo Y., Cai J., Xue H., Mattson M.P., Rao M.S. SDF1α/CXCR4 signaling stimulates β-catenin transcriptional activity in rat neural progenitors. Neurosci. Lett 2006, 398:291-295.
29. Hu T., Guo H., Wang W., Yu S., Han L., Jiang L., et al. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma. Oncol. Rep 2013, 30:1707-1714.
30. Li X., Ma Q., Xu Q., Liu H., Lei J., Duan W., et al. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of hedgehog pathway. Cancer Lett 2012, 322:169-176.
31. Kollmar O., Rupertus K., Scheuer C., Junker B., Tilton B., Schilling M.K., et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 2007, 9:862.
32. Soon L.L. A discourse on cancer cell chemotaxis: where to from here?. IUBMB Life 2007, 59:60-67.
33. Wang L., Li C.L., Wang L., Yu W.B., Yin H.P., Zhang G.Y., et al. Influence of CXCR4/SDF-1 axis on E-cadherin/β-catenin complex expression in HT29 colon cancer cells. World J. Gastroenterol 2011, 17:625.
34. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 2006, 127:469-480.
35. Le N., Franken P., Fodde R. Tumour-stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness. Br. J. Cancer 2008, 98:1886-1893.
36. Fodde R., Tomlinson I. Nuclear β-catenin expression and Wnt signalling: in defence of the dogma. J. Pathol 2010, 221:239-241.
37. Prasad C.P., Mirza S., Sharma G., Prashad R., DattaGupta S., Rath G., et al. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/β-catenin pathway in invasive ductal carcinoma of breast. Life Sci 2008, 83:318-325.
38. Zhao J.H., Luo Y., Jiang Y.G., He D.L., Wu C.T. Knockdown of β-catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1α. Cancer Invest 2011, 29:377-382.
39. Stemmer V., De Craene B., Berx G., Behrens J. Snail promotes Wnt target gene expression and interacts with β-catenin. Oncogene 2008, 27:5075-5080.
40. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009, 28:151-166.
41. Mongroo P.S., Rustgi A.K. The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol. Ther 2010, 10(3):219-222.
42. Brabletz S., Bajdak K., Meidhof S., Burk U., Niedermann G., Firat E., et al. The ZEB1/miR-200 feedback loop controls notch signalling in cancer cells. EMBO J. 2011, 30(4):770-782.
43. Azab A.K., Runnels J.M., Pitsillides C., Moreau A.-S., Azab F., Leleu X., et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 2009, 113:4341-4351.
44. Cruciat C.M., Niehrs C. Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb. Perspect. Biol 2013, 5:a015081.
45. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol 2002, 22:1172-1183.